State briefly the key evidence required in support of the safety and efficacy for:· New chemical entities· Generic medicines· Biosimilars
You are preparing a dossier for simultaneous submission to m…
You are preparing a dossier for simultaneous submission to multiple regulatory authorities, including the South African Health Products Regulatory Authority, European Medicines Agency, and U.S. Food and Drug Administration. To ensure consistency in the structure and presentation of data across all regions, you decide to follow an internationally harmonised format. Which document structure is specifically designed to standardise regulatory submissions across multiple jurisdictions?
A pharmaceutical company is preparing to register a new medi…
A pharmaceutical company is preparing to register a new medicine simultaneously in South Africa, the European Union, and the United States. The scientific data (Modules 2–5) are complete and aligned with ICH CTD requirements. However, the regulatory team proposes submitting the same Module 1 dossier to all three authorities: South African Health Products Regulatory Authority, European Medicines Agency, and U.S. Food and Drug Administration. What is the MOST appropriate regulatory strategy?
A company relies on assessment reports from the European Med…
A company relies on assessment reports from the European Medicines Agency to speed up approval in South Africa.Which pathway is being used?
The EU Variations Guideline and the SAHPRA Variations Addend…
The EU Variations Guideline and the SAHPRA Variations Addendum provide procedural guidance on how to classify and submit regulatory changes. When determining the regulatory requirements for a post-approval amendment, which other type of guidelines must be considered to ensure that the change meets all regulatory expectations?
A pharmaceutical company is preparing a post-approval variat…
A pharmaceutical company is preparing a post-approval variation for a medicine registered in South Africa. They notice the European Union (EU) Variations Guideline classifies changes into Type IA, IB, and II, while SAHPRA has published a Variations Addendum for local submissions. Which statement best describes the relationship between the EU Variations Guideline and the SAHPRA Variations Addendum?
Which of the following was part of the “Oslo process” (1993-…
Which of the following was part of the “Oslo process” (1993-2000), according to the report?
Which of the following has been used by Israel to take contr…
Which of the following has been used by Israel to take control over territories in the West Bank?
Let’s toss a pair of dice and look at the sum. The number of…
Let’s toss a pair of dice and look at the sum. The number of trials X it takes until I see a sum of 6 is obviously a Geom(p) random variable. Use the PRN U = 0.5 to generate X via inverse transform.
The Old State House in Boston would be considered a ________…
The Old State House in Boston would be considered a __________ source.